Nomura Holdings’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.71M | Buy |
+95,000
| New | +$1.8M | ﹤0.01% | 1175 |
|
|
2025
Q4 | – | Sell |
-27,515
| Closed | -$580K | – | 2147 |
|
|
2025
Q3 | $530K | Buy |
+27,515
| New | +$491K | ﹤0.01% | 1588 |
|
|
2025
Q2 | – | Sell |
-34,848
| Closed | -$1.49M | – | 1912 |
|
|
2025
Q1 | $2.22M | Sell |
34,848
-18,472
| -35% | -$1.94M | ﹤0.01% | 1020 |
|
|
2024
Q4 | $6.48M | Sell |
53,320
-4,109
| -7% | -$504K | 0.01% | 671 |
|
|
2024
Q3 | $7.17M | Sell |
57,429
-11,704
| -17% | -$1.62M | 0.02% | 540 |
|
|
2024
Q2 | $10.9M | Buy |
+69,133
| New | +$8.88M | 0.02% | 420 |
|
|
2023
Q2 | – | Sell |
-8,200
| Closed | -$1.13M | – | 1620 |
|
|
2023
Q1 | $1.13M | Buy |
+8,200
| New | +$1.06M | ﹤0.01% | 979 |
|
|
2022
Q3 | – | Sell |
-12,256
| Closed | -$927K | – | 1945 |
|
|
2022
Q2 | $927K | Buy |
12,256
+4,411
| +56% | +$325K | ﹤0.01% | 979 |
|
|
2022
Q1 | $647K | Buy |
+7,845
| New | +$601K | ﹤0.01% | 1234 |
|
|
2021
Q3 | – | Sell |
-22,248
| Closed | -$1.73M | – | 2200 |
|
|
2021
Q2 | $1.73M | Buy |
+22,248
| New | +$1.69M | ﹤0.01% | 914 |
|
|
2021
Q1 | – | Sell |
-18,000
| Closed | -$3.06M | – | 2248 |
|
|
2020
Q4 | $3.06M | Sell |
18,000
-39,081
| -68% | -$5.79M | 0.01% | 704 |
|
|
2020
Q3 | $8.03M | Buy |
+57,081
| New | +$8.67M | 0.02% | 397 |
|
|
2020
Q2 | – | Sell |
-11,000
| Closed | -$1.07M | – | 1262 |
|
|
2020
Q1 | $1.07M | Buy |
11,000
+10,200
| +1,275% | +$1.17M | ﹤0.01% | 566 |
|
|
2019
Q4 | $103K | Sell |
800
-11,700
| -94% | -$1.18M | ﹤0.01% | 1040 |
|
|
2019
Q3 | $957K | Buy |
+12,500
| New | +$1.48M | ﹤0.01% | 850 |
|
|
2019
Q2 | – | Sell |
-211,000
| Closed | -$25.6M | – | 1309 |
|
|
2019
Q1 | $24.9M | Buy |
211,000
+203,674
| +2,780% | +$26.2M | 0.11% | 148 |
|
|
2018
Q4 | $799K | Sell |
7,326
-8,722
| -54% | -$1.09M | ﹤0.01% | 897 |
|
|
2018
Q3 | $2.4M | Sell |
16,048
-2,352
| -13% | -$322K | 0.01% | 684 |
|
|
2018
Q2 | $2.43M | Buy |
+18,400
| New | +$1.74M | 0.01% | 668 |
|
|
2018
Q1 | – | Sell |
-322,069
| Closed | -$18M | – | 1657 |
|
|
2017
Q4 | $18M | Sell |
322,069
-101,914
| -24% | -$5.4M | 0.03% | 312 |
|
|
2017
Q3 | $19.2M | Buy |
+423,983
| New | +$16.9M | 0.04% | 247 |
|
|
2017
Q1 | – | Sell |
-44,720
| Closed | -$1.24M | – | 1596 |
|
|
2016
Q4 | $1.24M | Buy |
+44,720
| New | +$1.8M | ﹤0.01% | 1005 |
|
|
2014
Q4 | – | Sell |
-13,810
| Closed | -$306K | – | 2680 |
|
|
2014
Q3 | $306K | Buy |
+13,810
| New | +$312K | ﹤0.01% | 2164 |
|
Other funds holding SRPT
EAM
Nomura Holdings's SRPT Position: Q2 2026 in Review
Nomura Holdings opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 95,000 shares worth $1.71M. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in SRPT as recently as Q3 2025.
Nomura Holdings first reported a position in SRPT in Q3 2014 and has held it in 23 quarters since. The position peaked at $24.9M in Q1 2019. 298 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Nomura Holdings held 95,000 shares of Sarepta Therapeutics worth $1.71M as of Q2 2026.
- Sarepta Therapeutics was a new Nomura Holdings position in Q2 2026.
- Sarepta Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1175 holding.
- Nomura Holdings first reported a position in Sarepta Therapeutics in Q3 2014 and has held it in 23 quarters since.
- Nomura Holdings's Sarepta Therapeutics position peaked at $24.9M in Q1 2019.
- 298 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.